Posterior cortical atrophy (PCA) is a rare neurodegenerative disorder that has cerebral atrophy in the parietal, occipital, or occipitotemporal cortices and is characterized by visuospatial and visuoperceptual impairments. The most cases are pathologically compatible with Alzheimer's disease (AD). We describe a case of PCA in which a combination of imaging methods, in conjunction with symptoms and neurological and neuropsychological examinations, led to its being diagnosed and to AD being identified as its probable cause. Treatment with donepezil for 6 months mildly improved alexia symptoms, but other symptoms remained unchanged. A 59-year-old Japanese woman with progressive alexia, visual deficit, and mild memory loss was referred to our neurologic clinic for the evaluation of right homonymous hemianopsia. Our neurological examination showed alexia, constructional apraxia, mild disorientation, short-term memory loss, and right homonymous hemianopsia. These findings resulted in a score of 23 (of 30) points on the Mini-Mental State Examination. Occipital atrophy was identified, with magnetic resonance imaging (MRI) showing left-side dominance. The MRI data were quantified with voxel-based morphometry, and PCA was diagnosed on the basis of these findings. Single photon emission computed tomography with 123 I-N-isopropyl-p-iodoamphetamine showed hypoperfusion in the corresponding voxel-based morphometry occipital lobes. Additionally, the finding of hypoperfusion in the posterior associate cortex, posterior cingulate gyrus, and precuneus was consistent with AD. Therefore, the PCA was considered to be a result of AD. We considered Lewy body dementia as a differential diagnosis because of the presence of hypoperfusion in the occipital lobes. However, the patient did not meet the criteria for Lewy body dementia during the course of the disease. We therefore consider including PCA in the differential diagnoses to be important for patients with visual deficit, cognitive impairment, and cerebral atrophy in the parietal, occipital, or occipitotemporal cortices. A combination of imaging methods, including MRI and single photon emission computed tomography, may help identify probable causes of PCA. (J Nippon Med Sch 2016; 83: 87 92) 
Introduction
Posterior cortical atrophy (PCA) was first reported in a series of 5 cases by Benson et al in 1998 1 . This rare neurodegenerative disorder occurs at a relatively young age with cerebral atrophy in the parietal, occipital, or occipitotemporal cortices and is characterized by visuospatial and visuoperceptual impairment in the absence of primary ophthalmologic findings. Originally, PCA was thought to be an independent disease; however, the majority of the disorder is pathologically compatible with
Alzheimer's disease (AD). Other disorders reported to be associated with PCA include Lewy body dementia (DLB), corticobasal degeneration (CBD), and prion disease 2 6 .
On the basis of the primary disorders of PCA, imaging findings may be variable. Cross-sectional magnetic resonance imaging (MRI) voxel-based morphometry has shown widespread differences in gray matter between patients with PCA and healthy persons, with the most significant reductions found most often in regions of the occipital and parietal lobes and then followed by areas in the temporal lobe 7, 8 . In addition, in patients with symptoms for 5 or more years, atrophy is widespread throughout the cortex, including medial temporal lobe structures 9 . In comparison with AD, PCA demonstrates characteristic marked atrophy of the occipital lobe 10 . Several studies have found asymmetric atrophy patterns in PCA, but these differences could be due to selective biases in the diagnosis or to the inclusion of patients with prominent visual dysfunction 11 .
Data from functional imaging studies with single photon emission computed tomography (SPECT) and fluorodeoxyglucose positron emission tomography are largely consistent with structural changes in parieto-occipital areas 10,12 16 . Positron emission tomography has also shown that the bilateral frontal eye fields, in addition to posterior regions, contain specific areas of hypometabolism, which can occur secondary to loss of input from occipitoparietal regions and may cause oculomotor apraxia in PCA 10, 17 .
Although several studies have involved the neuroimaging of PCA, we now report a case in which the typi- -weighted magnetic resonance image Atrophy in bilateral occipital lobes is noted. Atrophy in the left occipital lobe is more prominent (arrowheads). In addition, hyperintense signal in subcortical white matter of the bilateral occipital lobes is noted, and volume loss in the white matter was also seen (arrows).
Fig. 2 Magnetic resonance volumetry
There is left predominant occipital cortical atrophy compared with the same age group of normal subjects. tioned group comparison. Significant occipital atrophy was identified with volumetry compared with that of a group of healthy subjects of the same age (Fig. 2) .
SPECT Imaging
Statistical mapping was performed with the following and medial occipital lobes is seen on the surface mapping image and the Z-score image. Low perfusion is also seen in the parietal lobe and precuneus (Fig. 3) .
Differential Diagnosis
In the differential diagnoses of homonymous hemianopsia, any involvement from the optic tracts to the optic radiation because of cerebral vascular diseases, tumors, infection, or trauma should be considered. In this patient, none of these was visualized on imaging. However, oc- PCA is composed of DLB, CBD and prion disease 2 6 . In Fig. 3 Single photon emission computed tomography image Surface mapping image (second row) and Z-score image (third row). The images created by the projection of pixels to the brain surface were defined as surface mapping images. On surface mapping images, the color gradation bar represents qualitative degree of cerebral perfusion impairment. Green represents relatively lower perfusion whereas red represents normal perfusion. Hypoperfusion is seen in the lateral and medial occipital lobes. The Z-score images were normalized with cerebellar perfusion. Color coding represents Z-scores compared with age-matched normal controls. Red represents more significant perfusion reduction. There is hypoperfusion in the lateral and medial occipital lobes on the Z-score image. There is also hypoperfusion in the parietal lobe and precuneus. 1 . Therefore, PCA was diagnosed.
We consider this patient to have a pathologic background of AD. Donepezil (an acetylcholinesterase inhibitor), at a dosage of 5 mg/day, was started on the basis of the presumed diagnosis of early AD. The 6-month follow-up examination showed mild improvement in the alexia. However, no improvement was seen in visual deficit or constitutional apraxia, which could be due to the short length of follow-up.
Discussion
This case was diagnosed as PCA caused by AD and was treated with an acetylcholinesterase inhibitor. In the diagnostic process, evaluations were made according to a detailed history of symptoms and neurological findings; biochemical findings; hematologic findings; neuropsychiatric examination; cerebral morphologic evaluation, such as brain MRI; and functional brain imaging, such as SPECT. As a result, we determined the primary disease of our patient and were able to start the appropriate treatment.
For the treatment of PCA, no definitive protocol has been established. However, case reports have stated that PCA or a visual form of AD is responsive to cholinesterase inhibitors 21, 22 . In both reports the responsiveness to cholinesterase inhibitors may be due to the causes of the PCA. We speculate that cholinesterase in- . In addition, patients who had PCA and homonymous hemianopsia were reported to have occipital and parietal white matter hyperintensity on T2-weighted images which could represent gliosis 31 .
Furthermore, a recent diffusion-tensor MRI study has demonstrated both cortical and white matter atrophy 32 .
These findings may provide new insights into PCA. 
